Seth Kroll

@sethkroll.bsky.social

Amateur photographer, lifelong dog-lover, micro-mobility enthusiast, Bostonian-by-choice. Also, communications at Wyss Institute at Harvard University.

Everyone is impacted by science, and in a world full of division, that can bring us together. Explore the impact of the abrupt changes in government funding for scientific research and the ways we have adapted to continue our work.

The Importance of Science - Part II

In a follow-up to our first Importance of Science video, we sit down with leaders of patient advocacy foundations, one of our board members, Wyss Lumineers (alumni), and a new set of researchers to re...

bit.ly

More 2026-2027 Validation Projects! The review committee initially selected 16 projects based on their scientific strength, commercial viability, innovativeness, and likelihood of achieving technology validation. Support from Harvard’s OVPR enabled us to fund 7 more highly rated proposals.

The Wyss Institute’s 2026-2027 Validation Projects

Each year, the Wyss Institute’s Validation Project program identifies technologies that are ready to move beyond discovery and into the validation phase. Through dedicated funding, technical resources...

wyss.harvard.edu

AI won't replace scientists, but it can help them ask better questions, design better experiments, and accelerate discovery. Learn how the Wyss Institute is advancing application-driven AI by combining computation with human biology, experimental validation, and translational science.

Accelerating Biomedical Innovation with AI through Collaborative Iteration

By Mariel Schoen Long before ChatGPT brought Artificial Intelligence (AI) into the public spotlight, scientists at the Wyss Institute were using AI-driven computational approaches, including machine l...

wyss.harvard.edu

The Food and Drug Administration approved the first mRNA flu vaccine, enabling use of a technology that will make it easier to rapidly target a widely prevalent or particularly virulent strain of the virus.

New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based flu vaccine - The Boston Globe

The FDA had initially refused to review the Cambridge-based biotech's application for approval, but eventually relented amid public backlash.

trib.al

An award from the Massachusetts Life Sciences Center will enable us to host a next-generation metabolomics and lipidomics analytical platform, which will allow researchers to creatively pursue new approaches to biomarker and drug discovery across multiple health and environmental challenges.

Wyss Institute receives Massachusetts Life Science Center award to advance metabolomics and lipidomics research across Massachusetts ecosystem

By Benjamin Boettner (BOSTON) — The Wyss Institute at Harvard University has received an award from the Massachusetts Life Science Center (MLSC), enabling it to host a next-generation metabolomics and...

wyss.harvard.edu

The PMC starts tomorrow! Learn more about Ken Carlson and Jay Culverwell's histories with the PMC, their deeply personal connections to cancer, how they're fighting cancer through their work at the Wyss, and what they'll bring back to the Institute on Monday.

Tackling cancer through riding and research

By Jessica Leff Imagine it’s 5:50 AM on a Saturday morning in August. The sun’s only been out for 20 minutes, but that hasn’t stopped thousands of bicyclists and an equal number of volunteers from gat...

wyss.harvard.edu

We're accelerating discovery through the Scientific Instrumentation @ Wyss Collaboratories Program. This collaboration between industry manufacturers and Wyss scientists and engineers is designed to drive progress, spur entrepreneurship, and incubate innovation through concurrent engineering.

The Wyss Instrumentation Program

The Scientific Instrumentation @ Wyss Collaboratories Program (Wyss Instrumentation Program) is a unique collaboration between industry manufacturers and our community of scientists and engineers to a...

bit.ly

CircaVent is a high-throughput drug screening platform that combines predictive algorithms, preclinical models, and human brain organoids to efficiently identify and test drugs that could treat the underlying causes of bipolar disorder.

CircaVent: A Drug Discovery Platform for Mental Health Conditions

CircaVent is a novel drug discovery platform that combines predictive algorithms, high-throughput preclinical models, and human organoids to identify and test drugs that could treat mental health cond...

wyss.harvard.edu

Changes to rules over federal research grants will have real consequences. For decades, merit-based peer review & sustained federal support helps the US lead in science and technology. Giving political appointees influence over individual awards risks this foundation news.harvard.edu/gazette/stor...

University opposes changes to federal-grant guidelines — Harvard Gazette

Letter argues that overhaul would politicize funding process, hamper health and science advances, damage nation’s security, competitiveness.

news.harvard.edu

“Air pollution fell substantially as Paris restricted car traffic and made way for parks, people-streets and bike-lanes.” Better for the climate, better for health, better for livability and quality of life. Common sense. Such a no-brainer, it’s remarkable that more cities HAVEN’T done the same.

Paris said au revoir to cars. Air pollution maps reveal a dramatic change.

Air pollution fell substantially as the city restricted car traffic and made way for parks and bike lanes.

washingtonpost.com

Discovery does not stop in difficult times. Stick with us; we won't give up. In this video, learn how abrupt changes in government funding for scientific research in 2025 have affected the trajectory of scientific research and the ways researchers have adapted to continue their high-impact work.

The Importance of Science - Part II

In a follow-up to our first Importance of Science video, we sit down with leaders of patient advocacy foundations, one of our board members, Wyss Lumineers (alumni), and a new set of researchers to re...

wyss.harvard.edu

Scientists tend to establish credibility by explaining what they know. Audiences are also asking: Why are you doing this work? Trust depends on demonstrating expertise AND helping people understand a scientist’s motivations, values, and commitment to the public good. news.vt.edu/articles/202...

Scientists’ credibility depends on audience and perceived motives

A new study identifies five audience "classes" based on people's perceptions of scientists’ credibility.

news.vt.edu

Scientists developed a better way to test immune responses to mRNA vaccines, potentially transforming mRNA vaccine research. This platform recapitulates immunological responses at the injection site and the adaptive immune responses that arise in lymph nodes. wyss.harvard.edu/news/recapit...

Recapitulating intramuscular vaccination with mRNA vaccines in patient-specific Lymphoid Organ Chips

By Benjamin Boettner (BOSTON) — The protective abilities of the Moderna and BioNTech mRNA vaccines developed against COVID-19 saved millions of lives during the pandemic and put this platform technolo...

wyss.harvard.edu

Two Wyss members, Ken Carlson and Jay Culverwell, will be riding the Pan-Mass Challenge this year. Both are avid cyclists with a personal connection to cancer. Learn more about their motivations, the event itself, their work at the Wyss, and what they take from the ride and bring back to the Wyss.

Tackling cancer through riding and research

By Jessica Leff Imagine it’s 5:50 AM on a Saturday morning in August. The sun’s only been out for 20 minutes, but that hasn’t stopped thousands of bicyclists and an equal number of volunteers from gat...

wyss.harvard.edu

“The way Mr. Fertitta sees it, giving Italians a glimpse of how the 0.1 percent live helps to make the kind of people-to-people connections that ambassadors are supposed to foster.” What is this logic?!? www.nytimes.com/2026/07/18/w...

As Trump Scraps With Meloni, His Envoy to Italy Is at Sea

Tilman J. Fertitta, the U.S. ambassador to Rome, is summering on his superyacht as President Trump squabbles with Prime Minister Giorgia Meloni of Italy.

nytimes.com